Patient awareness gaps drive poor treatment decisions: Limited knowledge that no IV glutathione is FDA-approved for skin lightening Lack of awareness about the 32% adverse event rate including serious complications Aesthetic clinic promotion continues despite regulatory warnings from multiple countries Misconception that higher cost ($2,000-$3,200) equals better results The 2025 Philippine FDA warning states there are no published guidelines for appropriate dosing regimens
Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S
An increasing number of studies have shown that calcium oxalate, urate, phosphate, and selenium deficiency induce ferroptosis and promote kidney stone formation through mechanisms such as oxidative stress, endoplasmic reticulum stress, and autophagy
As understanding of ferroptosis mechanisms deepens and multidisciplinary innovations progress, a multifaceted approach to targeting ferroptosis may ultimately emerge as a breakthrough for OA management by delaying disease progression and enhancing patients quality of life
But what drives this persistent exhaustion
And that distinction matters